IgA Glycosylation in IgA Nephropathy

  • Alice Allen
  • John Feehally
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 435)


IgA nephropathy (IgAN) is the commonest form of glomerulonephritis in developed countries where renal biopsy is widely practiced1. IgAN is defined by the deposition of IgA in the glomerular mesangium. Most typically, patients present with episodes of visible haematuria, which often concide with respiratory or gastrointestinal infection. At this early stage renal function may be preserved but slowly progressive renal failure is common. Up to 30% of patients with IgAN will require renal replacement therapy by dialysis or transplantation within 20 years of presentation2. Since IgAN is characteristically diagnosed in children and young adults, many of these patients will develop renal failure in young or middle age. The formidable personal, social and financial implications of renal failure emphasise the importance of investigating fundamental pathogenic processes in IgAN with the long term aim of interrupting disease progression.


Hinge Region Lectin Binding Asialoglycoprotein Receptor Vicia Villosa Lower Molecular Weight Band 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    G d’Amico. The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med, 245:709(1987).Google Scholar
  2. 2.
    G d’Amico. Clinical features and natural history in adults with IgA nephropathy. A J Kidney Dis, 12:353(1988).Google Scholar
  3. 3.
    FB Waldo. Is Henoch-Schönlein purpura the systemic form of IgA nephropathy?. Am J Kidney Dis, 12:373(1988).PubMedGoogle Scholar
  4. 4.
    J Feehally. Immune mechanisms in glomerular IgA deposition. Nephrol Dial Transplant, 3:361 (1988).PubMedGoogle Scholar
  5. 5.
    M-C Béné, G Faure. Mesangial IgA in IgA nephropathy arises from the mucosa. Am J KidneyDis, 12:406(1988).Google Scholar
  6. 6.
    L Layward, AC Allen, SJ Harper, JM Hattersley, J Feehally. Increased and prolonged production of specific polymeric IgA after systemic immunisation with tetanus toxoid in IgA nephropathy. Clin Exp Immunol, 88:394 (1992).PubMedCrossRefGoogle Scholar
  7. 7.
    L Layward, AC Allen, JM Hattersley, SJ Harper, J Feehally. Elevation of IgA in IgA nephropathy is localised in the serum and not saliva and is restricted to the IgAl subclass. Nephrol Dial Transplant, 8:25 (1993).PubMedGoogle Scholar
  8. 8.
    SJ Harper, JH Pringle, ACB Wicks, J Hattersley, L Layward, AC Allen, A Gillies, I Lauder, J Feehally. Expression of J chain mRNA in duodenal plasma cells in IgA nephropathy. Kidney Int, 45:836 (1994).PubMedCrossRefGoogle Scholar
  9. 9.
    SJ Harper, AC Allen, JH Pringle, J Feehally. Increased dimeric IgA producing B cells in the bone marrow in IgA nephropathy. J Clin Pathol, 49:38 (1996).PubMedCrossRefGoogle Scholar
  10. 10.
    SN Emancipator, ME Lamm. IgA nephropathy: pathogenesis of the most common form of glomerulonephritis. Lab Invest, 60:168 (1989).PubMedGoogle Scholar
  11. 11.
    M-C Béné, P Canton, C Amiel, T May, G Faure. Absence of mesangial IgA in AIDS: a postmortem study. Nephron, 58:425 (1991).PubMedCrossRefGoogle Scholar
  12. 12.
    V Montinaro, AR Esparza, T Cavallo, A Rifai. Antigen as mediator of glomerulr injury in experimental IgA nephropathy. Lab Invest, 64:508 (1991).PubMedGoogle Scholar
  13. 13.
    J Mestecky. Immunobiology of IgA. Am J Kidney Dis, 12:378 (1988).PubMedGoogle Scholar
  14. 14.
    J Baenziger, S Kornfeld. Structure of the carbohydrate units of IgAl immunoglobulin. II. Structure of the O-glycosidically linked oligosaccharide units. J Biol Chem, 249:7270(1974).PubMedGoogle Scholar
  15. 15.
    MC Field, RA Dwek, CJ Edge, TW Rademacher. O-linked oligosaccharides from human serum immunoglobulin A1. Biochem Soc Trans, 17:1034 (1989).PubMedGoogle Scholar
  16. 16.
    MA Kerr. The structure and function of human IgA. Biochem J, 271:285 (1990).PubMedGoogle Scholar
  17. 17.
    Z Moldoveanu, I Moro, J Radl, SR Thorpe, K Komiyama, J Mestecky. Site of catabolism of autologous and heterologous IgA in non-human primates. Scand J Immunol, 32:577 (1990).PubMedCrossRefGoogle Scholar
  18. 18.
    RJ Stockert, MS Kressner, JC Collins, I Sternlieb, AG Morell. IgA interaction with the asialoglycoprotein receptor. Proc Natl Acad Sci USA, 79:6229 (1982).PubMedCrossRefGoogle Scholar
  19. 19.
    N Jentoft. Why are proteins O-glyeosylated? Trends in Biochemical Sciences, 15:291 (1990).PubMedCrossRefGoogle Scholar
  20. 20.
    EF Hounsell, MJ Davies. Role of protein glycosylation in immune regulation. Annals Rheumatic Dis, 52:S22 (1993).CrossRefGoogle Scholar
  21. 21.
    H Lis, N Sharon. Protein glycosylation. Structural and functional aspects. Eur J Biochem, 218:1 (1993).PubMedCrossRefGoogle Scholar
  22. 22.
    C Gomez-Guerrero, E Gonzalez, J Egido. Evidence for a specific IgA receptor in rat and human mesangial cells. J Immunol, 151:7172 (1993).PubMedGoogle Scholar
  23. 23.
    AC Allen, MR Greer, C Combe, WW Stewart, SJ Harper, MA Kerr, J Feehally. Binding of human IgA to human leucocytes and mesangial cells. J Am Soc Nephrol, 5:739 (1994).Google Scholar
  24. 24.
    AC Allen, SJ Harper, J Feehally. Galactosylation of N-and O-linked carbohydrate moieties of IgAl and IgG in IgA nephropathy. Clin Exp Immunol, 100:470 (1995).PubMedCrossRefGoogle Scholar
  25. 25.
    AC Allen, F Willis, SJ Harper, TJ Beattie, J Feehally. Altered O-glycosylation of IgAl in Henoch-Schönlein purpura is restricted to subjects with nephritis. Nephrol Dial Transplant, in press (1996).Google Scholar
  26. 26.
    PM Andre, P le Pogamp, D Chevet. Impairment of jacalin binding to serum IgA in IgA nephropathy. J Clin Lab Anal, 4:115 (1990).PubMedCrossRefGoogle Scholar
  27. 27.
    Y Hiki, H Iwase, M Saitoh, Y Saitoh, A Horii, K Hotta, Y Kobayashi. Reactivity of glomerular and serum IgAl to jacalin in IgA nephropathy. Nephron, 72:429 (1996).PubMedCrossRefGoogle Scholar
  28. 28.
    J Mestecky, M Tomana, PA Crowley-Nowick, Z Moldoveanu, BA Julian, S Jackson. Defective galactosylation and clearance of IgAl molecules as a possible etiopathogenic factor in IgA nephropathy. Contrib Nephrol, 104:172 (1993).PubMedGoogle Scholar
  29. 29.
    R Coppo, A Amore, B Gianoglio, A Reyna, L Peruzzi, D Roccatello, D Alessi, LM Sena. Serum IgA and macromolecular IgA reacting with mesangial matrix components. Contrib Nephrol, 104:162 (1993).PubMedGoogle Scholar
  30. 30.
    D Baharaki, M Dueymes, R Perrichot, C Basset, R Lecorre, J Cledes, P Youinou. Aberrant glycosylation of IgA from patients with IgA nephropathy. Glycoconjugate J, 13:505 (1996).CrossRefGoogle Scholar
  31. 31.
    JS Axford, N Sumar, A Alavi, DA Isenberg, A Young, KB Bodman, IM Roitt. Changes in normal glycosylation mechanisms in autoimmune rheumatic disease. J Clin Invest, 89:1021 (1992).PubMedCrossRefGoogle Scholar
  32. 32.
    LT Lee, S Frank, DS de Jongh, C Howe. Immunochemical studies on Tn erythrocyte glycoprotein. Blood, 58:1228 (1981).PubMedGoogle Scholar
  33. 33.
    Y Hiki, H Iwase, T Kokubo, A Horii, A Tanaka, J Nishikido, K Hotta, Y Kobayashi. Association of asialo-galactosylβl-3N-acetylgalactosamine on the hinge with a conformational instability of jacalin-reactive immunoglobulin Al in immunoglobulin A nephropathy. J Am Soc Nephrol, 7:955 (1996).PubMedGoogle Scholar
  34. 34.
    M Matsuda, Y Mishige, K Takenouchi, T Tabe, A Moriyama, T Haruta, Y Ohtsubo, Y Uchida, Y Yasumoto, T Arima. Amino acid sequence of the hinge region of IgAl molecule can not be responsible for defective galactosylation in patients with IgA nephropathy. J Am Soc Nephrol 7:1323 (1996).Google Scholar
  35. 35.
    JU Baenziger. Protein-specific glycosyltransferases: how and why they do it! FASEB J, 8:1019 (1994).PubMedGoogle Scholar
  36. 36.
    AC Allen, PS Topham, SJ Harper, J Feehally. Reduced β 1,3 galactosyltransferase activity in the B cells of patients with IgA nephropathy. J Am Soc Nephrol, 6:820 (1995).Google Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Alice Allen
    • 1
  • John Feehally
    • 1
  1. 1.Department of NephrologyLeicester General HospitalLeicesterUK

Personalised recommendations